Unilife Corporation (NASDAQ:UNIS / ASX: UNS) is a developer and commercial supplier of a diversified portfolio of injectable drug delivery systems. More.
Driven by unmet, emerging market needs, we have established the most comprehensive portfolio of innovative, highly differentiated devices available to enable and enhance injectable therapies.
Featuring: The Unifill® Syringe, Unifill® Select, EZMix™ Dual Chamber Syringe, LISA™ Reusable Autoinjector, RITA™ Disposable Auto-injector, and Flex-Therapy™ Drug Pumps or Precision-Therapy™ Bolus Injectors
Unilife has introduced a new technology platform for ocular drug delivery - the Unilife Depot-Ject™.
Unilife trades on NASDAQ with ticker code UNIS, and the ASX ticker code for Unilife is UNS.
Sign up for email alerts
A New Industry Paradigm for Prefilled Success. March 2013 edition of Drug Development and Delivery magazine.
Alan Shortall interviewed by Griffin Securities on Device Platforms and New Commercial Opportunities - Part 2
Alan Shortall interviewed by Griffin Securities on Business and Financials - Part 1
Unilife AutoInfusor™ Bolus Injectors and drug pumps are cover story on Drug Development & Delivery magazine
Our Global Headquarters
Copyright © 2005 - 2013 Unilife Corporation.